These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 10378663)

  • 1. The effect of membrane permeability on ESRD: design of a prospective randomised multicentre trial.
    Locatelli F; Hannedouche T; Jacobson S; La Greca G; Loureiro A; Martin-Malo A; Papadimitriou M; Vanholder R
    J Nephrol; 1999; 12(2):85-8. PubMed ID: 10378663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction in beta2-microglobulin with super-flux versus high-flux dialysis membranes: results of a 6-week, randomized, double-blind, crossover trial.
    Pellicano R; Polkinghorne KR; Kerr PG
    Am J Kidney Dis; 2008 Jul; 52(1):93-101. PubMed ID: 18423807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dialyzer membrane permeability and survival in hemodialysis patients.
    Chauveau P; Nguyen H; Combe C; Chêne G; Azar R; Cano N; Canaud B; Fouque D; Laville M; Leverve X; Roth H; Aparicio M;
    Am J Kidney Dis; 2005 Mar; 45(3):565-71. PubMed ID: 15754279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of on-line high-flux hemofiltration versus low-flux hemodialysis on mortality in chronic kidney failure: a small randomized controlled trial.
    Santoro A; Mancini E; Bolzani R; Boggi R; Cagnoli L; Francioso A; Fusaroli M; Piazza V; Rapanà R; Strippoli GF
    Am J Kidney Dis; 2008 Sep; 52(3):507-18. PubMed ID: 18617304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective randomised European multicentre study of medium-long run mortality and morbidity comparing acetate-free biofiltration and bicarbonate dialysis.
    Santoro A; Panzetta G; Tessitore N; Atti M; Mancini E; Esteban J; London G; Ara JM; Miguel JL; Neumann KH; Opatrny K; Perez R; Perrone B; Wizemann V; Zucchelli P
    J Nephrol; 1999; 12(6):375-82. PubMed ID: 10626827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biocompatibility and permeability of dialyzer membranes do not affect anemia, erythropoietin dosage or mortality in japanese patients on chronic non-reuse hemodialysis: a prospective cohort study from the J-DOPPS II study.
    Yokoyama H; Kawaguchi T; Wada T; Takahashi Y; Higashi T; Yamazaki S; Fukuhara S; Akiba T; Akizawa T; Asano Y; Kurokawa K; Saito A;
    Nephron Clin Pract; 2008; 109(2):c100-8. PubMed ID: 18596379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of dialytic modalities on clinical outcomes in ESRD patients with familial Mediterranean fever.
    Sahin S; Sahin GM; Ergin H; Kantarci G
    Ren Fail; 2007; 29(3):315-9. PubMed ID: 17497446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of high-flux hemodialysis on renal anemia.
    Ayli D; Ayli M; Azak A; Yüksel C; Kosmaz GP; Atilgan G; Dede F; Abayli E; Camlibel M
    J Nephrol; 2004; 17(5):701-6. PubMed ID: 15593038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New dialysis therapy modalities: what role do they play in the hemodialysis patient's outcome?].
    Mandolfo S; Imbasciati E
    G Ital Nefrol; 2002; 19(1):22-30. PubMed ID: 12165942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of hemodiafiltration with on-line endogenous reinfusion (on-line HFR) on anemia: design of a European, open, randomised, multicentre trial. European Collaborative Study.
    J Nephrol; 2000; 13(1):34-42. PubMed ID: 10720212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective randomized cross-over long-term comparison of online haemodiafiltration and ultrapure high-flux haemodialysis.
    Schiffl H
    Eur J Med Res; 2007 Jan; 12(1):26-33. PubMed ID: 17363355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evaluation of postdialysis L-carnitine administration and its effect on weekly requiring doses of rHuEPO in hemodialysis patients.
    Kadiroglu AK; Yilmaz ME; Sit D; Kara IH; Isikoglu B
    Ren Fail; 2005; 27(4):367-72. PubMed ID: 16060121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hypertension in hemodialysis patients in Andalucia].
    García Cortés MJ; Ceballos M;
    Nefrologia; 2004; 24(2):149-57. PubMed ID: 15219090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The MPO Study: just a European HEMO Study or something very different?
    Locatelli F; Gauly A; Czekalski S; Hannedouche T; Jacobson SH; Loureiro A; Martin-Malo A; Papadimitriou M; Passlick-Deetjen J; Ronco C; Vanholder R; Wizemann V;
    Blood Purif; 2008; 26(1):100-4. PubMed ID: 18182806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined treatment with steroids and azathioprine in IgA nephropathy: design of a prospective randomised multicentre trial.
    Locatelli F; Pozzi C; Del Vecchio L; Andrulli S; Pani A; Fogazzi G; Altieri P; Ponticelli C
    J Nephrol; 1999; 12(5):308-11. PubMed ID: 10630693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrovascular disease in maintenance hemodialysis patients: results of the HEMO Study.
    Delmez JA; Yan G; Bailey J; Beck GJ; Beddhu S; Cheung AK; Kaysen GA; Levey AS; Sarnak MJ; Schwab SJ;
    Am J Kidney Dis; 2006 Jan; 47(1):131-8. PubMed ID: 16377394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical dialysis: new problems and new prospects].
    Locatelli F; Manzoni C; Pozzoni P; Pontoriero G; Di Filippo L
    G Ital Nefrol; 2004; 21(2):156-64. PubMed ID: 15351950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of intravenous continuous erythropoietin receptor activator: a 19-week, phase II, multicenter, randomized, open-label, dose-finding study with a 12-month extension phase in patients with chronic renal disease.
    Besarab A; Salifu MO; Lunde NM; Bansal V; Fishbane S; Dougherty FC; Beyer U;
    Clin Ther; 2007 Apr; 29(4):626-39. PubMed ID: 17617286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Renal replacement therapy by hemodialysis: an overview].
    Jacobs C
    Nephrol Ther; 2009 Jul; 5(4):306-12. PubMed ID: 19481513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.